Author

A. H. Abdullah

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Nov 2026

Synthesis, in silico studies, and in vitro evaluation of novel isoindigo inhibitors targeting wild-type and D835Y mutant FLT3

FMS-like tyrosine kinase 3 (FLT3) is a validated therapeutic target, but resistance mutations such as D835Y compromise its therapeutic utility by conferring resistance to existing inhibitors and limiting therapeutic options in FLT3-driven cancers, such as Acute Myeloid Leukemia (AML). In order to address this challenge...

Mohammed M. Abadleh, A. H. Abdullah, Ahmed Adel et al. · RSC Advances · 0 citations

Sep 2026

Synthesis of Novel Benzoxazole–Piperazine Hybrids as Anticancer Leads: Biological, Molecular Docking, and ADMET Evaluations

The synthesized benzoxazole hybrid compounds showed promising anticancer activity with acceptable ADMET properties; however, further structural optimization and mechanistic studies are needed to validate the molecular targets and improve safety and pharmacokinetic profiles.

Mahmoud A. Al-Sha'er, A. H. Abdullah, Almeqdad Y. Habashneh et al. · Chemistry Africa · 0 citations